Press release content from Business Wire. The AP news staff was not involved in its creation.
GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit
April 14, 2021 GMT
LEIDEN, Netherlands & BILBAO, Spain (BUSINESS WIRE) Apr 14, 2021
ADVERTISEMENT
The test measures the presence of neutralizing antibodies (NAbs) in patients recovering from COVID-19 or receiving a vaccine. It is the only U.S. FDA Emergency Use Authorized (EUA) serology test for neutralizing antibodies from recent and prior SARS-CoV-2 infections. The kit is also CE marked (Europe) and has received HSA provisional approval (Singapore), ANVISA in Brazil, ANMAT in Argentina and has recently received clearance from the Ministry of Health and Prevention (MOHAP) in the United Arab Emirates as a medical device.
GenScript and G42 Healthcare announce collaboration to provide innovative solutions to fight against COVID-19
prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.
GenScript and G42 Healthcare announce collaboration to provide innovative solutions to fight against COVID-19
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SINGAPORE, March 16, 2021 /PRNewswire/ GenScript Biotech Corporation ( GenScript , Stock Code: 1548.HK) receives the Best Contract Research Organization Award on the 4
th Annual Asia Pacific Bioprocessing Excellence Awards Ceremony 2021 held on 16
th March 2021.
The award follows GenScript s CDMO segment, GenScript Probio recognition at the Korea Bioprocessing Excellence Awards in 2020 for the Bioprocessing Excellence in CDMO Services .
Mr. Johnson Wang, President of GenScript Asia Pacific Division giving speech during the 4th Asia Pacific Bioprocessing Excellence Award.
The Asia-Pacific Bioprocessing Excellence Awards seeks to give recognition to exceptional bioprocessing experts, organizations and technologies that facilitate bio manufacturing excellence at enhanced speed, reduced cost and superior quality. GenScript is recognized to provide excellent CRO services with strong technical capabilities and reasonable cost without compr
22 febbraio 2021 10:13
Fonte: Adnkronos
#salute-e-benessere
NANJING, China, Feb. 22, 2021 /PRNewswire/ On February 21, 2021, GenScript ProBio and SunRock Biopharma, a company focused on the development of antibody therapeutics targeting cancer, announced a collaboration spanning preclinical discovery to large scale GMP manufacturing for SunRock s CCR9 therapeutic antibody candidates. GenScript ProBio will provide SunRock Biopharma a one-stop-solution from antibody discovery, cell line development, process development to GMP drug substance and drug product manufacturing services.
By leveraging complementary strengths and capabilities, the parties are committed to the R&D, manufacturing process development, NMPA, FDA & EMA IND filings of CCR9 therapeutic antibodies, towards rapid development of novel antibody therapeutics.